Original Research Article I Volume 5 I Issue 4 I 2017

Study of combination of ascorbic acid and N-acetylcysteine in prevention of contrast induced nephropathy in patients with moderate renal insufficiency

Amin Roshdi Soliman; Rabab Mahmoud Ahmed; Ahmed Abdalla; Mahmoud Soliman

Biolife; 2017, 5(4), pp 527-534

DOI:https://doi.org/10.5281/zenodo.7393076

Abstract:

Introduction and aims: Despite fluid administration is the most effective strategy in contrast induced nephropathy (CIN) prevention, still the estimated prevalence of CIN up to 50% in high-risk patients. There is still a great debate as regarding the administration of antioxidants in reduction of CIN incidence. This study aims to determine whether addition of ascorbic acid to IV acetylcysteine could reduce CIN prevalence in patients with moderate chronic kidney disease.

Keywords:

Ascorbic acid; N-Acetylcysteine; Contrast Nephropathy; Moderate CKD

References:

  1. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: Pathogenesis, risk factors & preventive strategies. CMAJ. 2005;172:1461–71.
  2. Bartels ED, Brun GV, Gammeltoft A, Gjorup PA. Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand. 1954;150:297–302. 
  3. Hossein Nough,  a Fatemeh Eghbal, a Mohammad hossein Soltani, a Farzaneh Nejafi, a Hossein Falahzadeh, a Habib Fazel, and Mehrdad Sheikhvatanb. Incidence and Main Determinants of Contrast-Induced Nephropathy following Coronary Angiography or Subsequent Balloon Angioplasty. Cardiorenal Med. 2013 Jul; 3(2): 128–135.
  4. Mohammed Habib, Alaa Hillis, Amen Hammad. N-Acetylcysteine and/or Ascorbic Acid versus Placebo to Prevent Contrast-Induced Nephropathy in Patients Undergoing Elective Cardiac Catheterization: The NAPCIN Trial; A Single-Center, Prospective, Randomized Trial Mohammed Saudi J Kidney Dis Transpl 2016; 27(1):55-61.
  5. Wattanakit K, Folsom AR, Selvin E, et al. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol 2007; 18:629.
  6. De Lima JJG, Sabbaga E, Vieira MLC, et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension. 2003; 42:263–8.
  7. Gonzales DA, Norsworthy KJ, Kern SJ, et al. A meta-analysis of n-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med 2007; 5:32.
  8. Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008; 148:284–94.
  9. Biondi-Zoccai GG, Lotrionte M, Abbate A, et al. Compliance with quorum and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study. BMJ 2006; 332:202–9.
  10. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004; 110:2837–42.
  11. Roger Rear, Robert M Bell, Derek J Hausenloy. Contrast-induced nephropathy following angiography and cardiac interventions. BMJ 2016; 0:1–11.
  12. Windecker S, Kolh P, Alfonso F, et al., Authors/Task Force members. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35:2541–619....

Article Dates:

Received: 3 October 2017; Accepted: 23 November2017; Published: 4 December 2017

How To Cite:

Amin Roshdi Soliman, Rabab Mahmoud Ahmed, Ahmed Abdalla, & Mahmoud Soliman. (2022). Study of combination of ascorbic acid and N-acetylcysteine in prevention of contrast induced nephropathy in patients with moderate renal insufficiency. Biolife, 5(4), 527–534. https://doi.org/10.5281/zenodo.7393076Amin Roshdi Soliman, Rabab Mahmoud Ahmed, Ahmed Abdalla, & Mahmoud Soliman. (2022). Study of combination of ascorbic acid and N-acetylcysteine in prevention of contrast induced nephropathy in patients with moderate renal insufficiency. Biolife, 5(4), 527–534. https://doi.org/10.5281/zenodo.7393076

Download Full Paper: PDF
Submit Manuscript
Join as Reviewer / Editor

Logo


Logo